{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T07:16:45Z","timestamp":1756192605999,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10792-021-02209-x","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T09:02:58Z","timestamp":1641373378000},"page":"2107-2116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The evaluation of the efficacy of adalimumab in refractory non-infectious uveitis with ultra-widefield fundus fluorescein angiography"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7882-9076","authenticated-orcid":false,"given":"Dilek","family":"Uzlu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00fc\u015fra","family":"K\u00f6se","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurettin","family":"Akyol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidayet","family":"Erd\u00f6l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"G\u00fcnay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"issue":"3","key":"2209_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ophtha.2003.06.014","volume":"111","author":"DC Gritz","year":"2004","unstructured":"Gritz DC, Wong IG (2004) Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 111(3):491\u2013500","journal-title":"Ophthalmology"},{"issue":"4","key":"2209_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1076\/ocii.10.4.263.15592","volume":"10","author":"JH Chang","year":"2002","unstructured":"Chang JH, Wakefield D (2002) Uveitis: a global perspective. Ocul Immunol Inflamm 10(4):263\u2013279","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"2209_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1089\/jop.2007.0104","volume":"24","author":"M Diaz-Llopis","year":"2008","unstructured":"Diaz-Llopis M, Garc\u00eda-Delpech S, Salom D et al (2008) Adalimumab therapy for refractory uveitis: a pilot study. J Ocul Pharmacol Ther 24(3):351\u2013361","journal-title":"J Ocul Pharmacol Ther"},{"issue":"8","key":"2209_CR4","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.ophtha.2012.02.018","volume":"119","author":"M D\u00edaz-Llopis","year":"2012","unstructured":"D\u00edaz-Llopis M, Salom D, Garcia-de-Vicu\u00f1a C et al (2012) Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients. Ophthalmology 119(8):1575\u20131581","journal-title":"Ophthalmology"},{"issue":"8","key":"2209_CR5","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1002\/art.21231","volume":"52","author":"I Tugal-Tutkun","year":"2005","unstructured":"Tugal-Tutkun I, Mudun A, Urgancioglu M et al (2005) Efficacy of infliximab in the treatment of uveitisthat is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Beh\u00e7et\u2019s disease: an open-label trial. Arthritis Rheum 52(8):2478\u20132484","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2209_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000055677","volume":"33","author":"M SantosLacomba","year":"2001","unstructured":"SantosLacomba M, MarcosMart\u00edn C, GallardoGalera JM et al (2001) Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res 33(5):251\u2013255","journal-title":"Ophthalmic Res"},{"issue":"12","key":"2209_CR7","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1136\/bjophthalmol-2017-311234","volume":"102","author":"JT Lee","year":"2018","unstructured":"Lee JT, Yates WB, Rogers S et al (2018) Adalimumab for the treatment of refractory active and inactive non-infectious uveitis. Br J Ophthalmol 102(12):1672\u20131678","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"2209_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3109\/09273948.2010.483314","volume":"18","author":"A Bawazeer","year":"2010","unstructured":"Bawazeer A, Raffa LH, Nizamuddin SH (2010) Clinical experience with adalimumab in the treatment of ocular Beh\u00e7et disease. Ocul Immunol Inflamm 18(3):226\u2013232","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"2209_CR9","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1509852","volume":"375","author":"GJ Jaffe","year":"2016","unstructured":"Jaffe GJ, Dick AD, Br\u00e9zin AP et al (2016) Adalimumab in patients with active noninfectious uveitis. N Engl J Med 375(10):932\u2013943","journal-title":"N Engl J Med"},{"issue":"10050","key":"2209_CR10","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","volume":"388","author":"QD Nguyen","year":"2016","unstructured":"Nguyen QD, Merrill PT, Jaffe GJ et al (2016) Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet 388(10050):1183\u20131192","journal-title":"Lancet"},{"issue":"3","key":"2209_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140(3):509\u2013516","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"2209_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","volume":"92","author":"RB Nussenblatt","year":"1985","unstructured":"Nussenblatt RB, Palestine AG, Chan CC et al (1985) Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 92(4):467\u2013471","journal-title":"Ophthalmology"},{"issue":"5","key":"2209_CR13","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ophtha.2004.12.034","volume":"112","author":"RB Nussenblatt","year":"2005","unstructured":"Nussenblatt RB, Peterson JS, Foster CS et al (2005) Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series. Ophthalmology 112(5):764\u2013770","journal-title":"Ophthalmology"},{"issue":"1","key":"2209_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1167\/iovs.12-10138","volume":"54","author":"M Busch","year":"2013","unstructured":"Busch M, Bauer D, Hennig M et al (2013) Effects of systemic and intravitreal TNF-\u03b1 inhibition in experimental autoimmune uveo retinitis. Invest Ophthalmol Vis Sci 54(1):39\u201346","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"2209_CR15","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","volume":"121","author":"G Levy-Clarke","year":"2014","unstructured":"Levy-Clarke G, Jabs DA, Read RW et al (2014) Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology 121(3):785\u201396.e3","journal-title":"Ophthalmology"},{"issue":"2","key":"2209_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/25785826.2019.1642080","volume":"42","author":"E Hasegawa","year":"2019","unstructured":"Hasegawa E, Takeda A, Yawata N et al (2019) The effectiveness of adalimumab treatment for non-infectious uveitis. Immunol Med 42(2):79\u201383","journal-title":"Immunol Med"},{"issue":"9","key":"2209_CR17","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.ophtha.2018.02.020","volume":"125","author":"JL Mart\u00edn-Varillas","year":"2018","unstructured":"Mart\u00edn-Varillas JL, Calvo-R\u00edo V, Beltr\u00e1n E et al (2018) Successful optimization of adalimumab therapy in refractory uveitis due to Beh\u00e7et\u2019s disease. Ophthalmology 125(9):1444\u20131451","journal-title":"Ophthalmology"},{"issue":"9","key":"2209_CR18","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1136\/bjo.2010.194464","volume":"95","author":"H Keino","year":"2011","unstructured":"Keino H, Okada AA, Watanabe T et al (2011) Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet\u2019s disease on infliximab therapy. Br J Ophthalmol 95(9):1245\u20131250","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"2209_CR19","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1097\/IAE.0000000000000197","volume":"34","author":"M Mesquida","year":"2014","unstructured":"Mesquida M, Lloren\u00e7 V, Fontenla JR et al (2014) Use of ultra-wide-field retinal imaging in the management of active Beh\u00e7et retinal vasculitis. Retina 34(10):2121\u20132127","journal-title":"Retina"},{"issue":"1","key":"2209_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1869-5760-3-30","volume":"3","author":"HA Leder","year":"2013","unstructured":"Leder HA, Campbell JP, Sepah YJ et al (2013) Ultra-wide-field retinal imaging in the management of non-infectious retinal vasculitis. J Ophthalmic Inflamm Infect 3(1):30","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"2","key":"2209_CR21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3390\/jcm9020510","volume":"9","author":"V Pirani","year":"2020","unstructured":"Pirani V, Pelliccioni P, De Turris S et al (2020) Intraocular inflammation control and changes in retinal and choroidal architecture in refractory non-infectious uveitis patients after adalimumab therapy. J Clin Med 9(2):510","journal-title":"J Clin Med"},{"issue":"1","key":"2209_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10067-016-3480-x","volume":"36","author":"C Fabiani","year":"2017","unstructured":"Fabiani C, Vitale A, Emmi G et al (2017) Efficacy and safety of adalimumab in Beh\u00e7et\u2019s disease-related uveitis: a multicenter retrospective observational study. Clin Rheumatol 36(1):183\u2013189","journal-title":"Clin Rheumatol"},{"issue":"10","key":"2209_CR23","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1007\/s10067-018-4133-z","volume":"37","author":"C Fabiani","year":"2018","unstructured":"Fabiani C, Sota J, Rigante D et al (2018) Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies. Clin Rheumatol 37(10):2805\u20132809","journal-title":"Clin Rheumatol"},{"issue":"12","key":"2209_CR24","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1097\/IAE.0000000000000624","volume":"35","author":"PK Sharma","year":"2015","unstructured":"Sharma PK, Markov GT, Bajwa A et al (2015) Long-term efficacy of systemic infliximab in recalcitrant retinal vasculitis. Retina 35(12):2641\u20132646","journal-title":"Retina"},{"issue":"9","key":"2209_CR25","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/eye.2014.138","volume":"28","author":"H Keino","year":"2014","unstructured":"Keino H, Okada AA, Watanabe T et al (2014) Long-termefficacy of infliximab on background vascular leakage in patients with Beh\u00e7et\u2019s disease. Eye (London) 28(9):1100\u20131106","journal-title":"Eye (London)"},{"key":"2209_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jaut.2015.06.005","volume":"62","author":"H Vallet","year":"2015","unstructured":"Vallet H, Riviere S, Sanna A et al (2015) Efficacy of anti-TNF alpha in severe and\/or refractory Beh\u00e7et\u2019s disease: multicenter study of 124 patients. J Autoimmun 62:67\u201374","journal-title":"J Autoimmun"},{"issue":"3","key":"2209_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3109\/09273948.2015.1134581","volume":"25","author":"K Durrani","year":"2017","unstructured":"Durrani K, Kempen JH, Ying GS et al (2017) Adalimumab for ocular inflammation. Ocul Immunol Inflamm 25(3):405\u2013412","journal-title":"Ocul Immunol Inflamm"},{"issue":"9","key":"2209_CR28","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.ophtha.2013.01.069","volume":"120","author":"JH Kempen","year":"2013","unstructured":"Kempen JH, Sugar EA, Jaffe GJ et al (2013) Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema. Ophthalmology 120(9):1852\u20131859","journal-title":"Ophthalmology"},{"issue":"2","key":"2209_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ajo.2012.02.003","volume":"154","author":"J Ossewaarde-vanNorel","year":"2012","unstructured":"Ossewaarde-vanNorel J, Camfferman LP, Rothova A (2012) Discrepancies between fluorescein angiography and optical coherence tomography in macular edema in uveitis. Am J Ophthalmol 154(2):233\u2013239","journal-title":"Am J Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-02209-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-021-02209-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-02209-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T13:38:52Z","timestamp":1657892332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-021-02209-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["2209"],"URL":"https:\/\/doi.org\/10.1007\/s10792-021-02209-x","relation":{},"ISSN":["1573-2630"],"issn-type":[{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2022,1,5]]},"assertion":[{"value":"27 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by Karadeniz Technical University, Faculty of Medicine, Ethic Council on 2020\/209.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}